Cargando…
Mitochondrial DNA abnormalities and metabolic syndrome
Metabolic syndrome (MetS) is a complex pathological condition that involves disrupted carbohydrate, protein, and fat metabolism in the human body, and is a major risk factor for several chronic diseases, including diabetes, cardiovascular disease, and cerebrovascular disease. While the exact pathoge...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036395/ https://www.ncbi.nlm.nih.gov/pubmed/36968196 http://dx.doi.org/10.3389/fcell.2023.1153174 |
_version_ | 1784911644377219072 |
---|---|
author | Ding, Xudong Fang, Tingting Pang, Xiaoqi Pan, Xueru Tong, Aiying Lin, Ziyi Zheng, Shikuan Zheng, Ningning |
author_facet | Ding, Xudong Fang, Tingting Pang, Xiaoqi Pan, Xueru Tong, Aiying Lin, Ziyi Zheng, Shikuan Zheng, Ningning |
author_sort | Ding, Xudong |
collection | PubMed |
description | Metabolic syndrome (MetS) is a complex pathological condition that involves disrupted carbohydrate, protein, and fat metabolism in the human body, and is a major risk factor for several chronic diseases, including diabetes, cardiovascular disease, and cerebrovascular disease. While the exact pathogenesis of metabolic syndrome is not yet fully understood, there is increasing evidence linking mitochondrial dysfunction, which is closely related to the mitochondrial genome and mitochondrial dynamics, to the development of this condition. Recent advancements in genetic sequencing technologies have allowed for more accurate detection of mtDNA mutations and other mitochondrial abnormalities, leading to earlier diagnosis and intervention in patients with metabolic syndrome. Additionally, the identification of specific mechanisms by which reduced mtDNA copy number and gene mutations, as well as abnormalities in mtDNA-encoded proteins and mitochondrial dynamics, contribute to metabolic syndrome may promote the development of novel therapeutic targets and interventions, such as the restoration of mitochondrial function through the targeting of specific mitochondrial defects. Additionally, advancements in genetic sequencing technologies may allow for more accurate detection of mtDNA mutations and other mitochondrial abnormalities, leading to earlier diagnosis and intervention in patients with MetS. Therefore, strategies to promote the restoration of mitochondrial function by addressing these defects may offer new options for treating MetS. This review provides an overview of the research progress and significance of mitochondrial genome and mitochondrial dynamics in MetS. |
format | Online Article Text |
id | pubmed-10036395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100363952023-03-25 Mitochondrial DNA abnormalities and metabolic syndrome Ding, Xudong Fang, Tingting Pang, Xiaoqi Pan, Xueru Tong, Aiying Lin, Ziyi Zheng, Shikuan Zheng, Ningning Front Cell Dev Biol Cell and Developmental Biology Metabolic syndrome (MetS) is a complex pathological condition that involves disrupted carbohydrate, protein, and fat metabolism in the human body, and is a major risk factor for several chronic diseases, including diabetes, cardiovascular disease, and cerebrovascular disease. While the exact pathogenesis of metabolic syndrome is not yet fully understood, there is increasing evidence linking mitochondrial dysfunction, which is closely related to the mitochondrial genome and mitochondrial dynamics, to the development of this condition. Recent advancements in genetic sequencing technologies have allowed for more accurate detection of mtDNA mutations and other mitochondrial abnormalities, leading to earlier diagnosis and intervention in patients with metabolic syndrome. Additionally, the identification of specific mechanisms by which reduced mtDNA copy number and gene mutations, as well as abnormalities in mtDNA-encoded proteins and mitochondrial dynamics, contribute to metabolic syndrome may promote the development of novel therapeutic targets and interventions, such as the restoration of mitochondrial function through the targeting of specific mitochondrial defects. Additionally, advancements in genetic sequencing technologies may allow for more accurate detection of mtDNA mutations and other mitochondrial abnormalities, leading to earlier diagnosis and intervention in patients with MetS. Therefore, strategies to promote the restoration of mitochondrial function by addressing these defects may offer new options for treating MetS. This review provides an overview of the research progress and significance of mitochondrial genome and mitochondrial dynamics in MetS. Frontiers Media S.A. 2023-03-10 /pmc/articles/PMC10036395/ /pubmed/36968196 http://dx.doi.org/10.3389/fcell.2023.1153174 Text en Copyright © 2023 Ding, Fang, Pang, Pan, Tong, Lin, Zheng and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Ding, Xudong Fang, Tingting Pang, Xiaoqi Pan, Xueru Tong, Aiying Lin, Ziyi Zheng, Shikuan Zheng, Ningning Mitochondrial DNA abnormalities and metabolic syndrome |
title | Mitochondrial DNA abnormalities and metabolic syndrome |
title_full | Mitochondrial DNA abnormalities and metabolic syndrome |
title_fullStr | Mitochondrial DNA abnormalities and metabolic syndrome |
title_full_unstemmed | Mitochondrial DNA abnormalities and metabolic syndrome |
title_short | Mitochondrial DNA abnormalities and metabolic syndrome |
title_sort | mitochondrial dna abnormalities and metabolic syndrome |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036395/ https://www.ncbi.nlm.nih.gov/pubmed/36968196 http://dx.doi.org/10.3389/fcell.2023.1153174 |
work_keys_str_mv | AT dingxudong mitochondrialdnaabnormalitiesandmetabolicsyndrome AT fangtingting mitochondrialdnaabnormalitiesandmetabolicsyndrome AT pangxiaoqi mitochondrialdnaabnormalitiesandmetabolicsyndrome AT panxueru mitochondrialdnaabnormalitiesandmetabolicsyndrome AT tongaiying mitochondrialdnaabnormalitiesandmetabolicsyndrome AT linziyi mitochondrialdnaabnormalitiesandmetabolicsyndrome AT zhengshikuan mitochondrialdnaabnormalitiesandmetabolicsyndrome AT zhengningning mitochondrialdnaabnormalitiesandmetabolicsyndrome |